"During this challenging time, we are doing everything possible to ensure our employees remain safe, our patients receive their medicines, and assistance is available to help those most deeply impacted by the COVID-19 pandemic." - Richard Gonzalez, CEO
Supporting COVID-19 clinical research
As a global biopharmaceutical company, AbbVie is involved in a number
of efforts to help positively impact the COVID-19 crisis. For example,
we have initiated a Phase 2 study of IMBRUVICA in patients with
COVID-19 infection. The goal of this study is to determine whether
IMBRUVICA is able to improve patient outcomes by diminishing the
immune response known as the cytokine storm that contributes to the
morbidity and mortality in COVID-19.
You can also learn more about our collaboration with researchers to develop an antibody therapy to prevent and treat COVID-19.
AbbVie has donated $35 million to help support underserved communities and healthcare systems working to address the impact of the COVID-19 global pandemic. AbbVie’s partners are:
- International Medical Corps to help create capacity to treat patients at overburdened hospitals in the U.S. AbbVie’s donation will support the creation and operation of 20 mobile field hospitals to expand available triage at existing facilities, improve patient flow and keep COVID-19 patients separated from other patients. These standalone mobile field hospitals are being built in U.S. hotspots.
- Direct Relief to provide equipment and supplies in the hardest-hit European countries. This support will enable the procurement and delivery of oxygen concentrators, ventilators and personal protective equipment to frontline healthcare workers and patients.
- Feeding America to protect the most vulnerable, including the elderly, by enabling access to food and essential household supplies with minimal contact. Feeding America has created a new model of home delivery and drive-through service.
As part of the company’s $35 million philanthropic commitment to fighting COVID, AbbVie set up a $5 million COVID-19 Community Resilience Fund. In May, the company announced the 26 nonprofits that received funds to help front-line healthcare workers and vulnerable populations in hard-hit communities. Learn more.
AbbVie also doubled the AbbVie Foundation match for COVID-19-related
contributions by employees, providing $2 for every $1 employees donate
to a qualified nonprofit.